These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 27221627)

  • 21. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
    Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
    J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.
    Arnone D; Saraykar S; Salem H; Teixeira AL; Dantzer R; Selvaraj S
    Neurosci Biobehav Rev; 2018 Sep; 92():477-485. PubMed ID: 29940237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suicidality and Activation of the Kynurenine Pathway of Tryptophan Metabolism.
    Bryleva EY; Brundin L
    Curr Top Behav Neurosci; 2017; 31():269-284. PubMed ID: 27221623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
    Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
    Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
    Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
    Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.
    Larsson MK; Faka A; Bhat M; Imbeault S; Goiny M; Orhan F; Oliveros A; Ståhl S; Liu XC; Choi DS; Sandberg K; Engberg G; Schwieler L; Erhardt S
    Neurochem Res; 2016 Sep; 41(9):2243-55. PubMed ID: 27165635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral and central kynurenine pathway abnormalities in major depression.
    Paul ER; Schwieler L; Erhardt S; Boda S; Trepci A; Kämpe R; Asratian A; Holm L; Yngve A; Dantzer R; Heilig M; Hamilton JP; Samuelsson M
    Brain Behav Immun; 2022 Mar; 101():136-145. PubMed ID: 34999196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
    Miura H; Ozaki N; Sawada M; Isobe K; Ohta T; Nagatsu T
    Stress; 2008 May; 11(3):198-209. PubMed ID: 18465467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2/ARE pathway in mouse model of depression: In-vivo and In-silico studies.
    Bansal Y; Singh R; Sodhi RK; Khare P; Dhingra R; Dhingra N; Bishnoi M; Kondepudi KK; Kuhad A
    Neuropharmacology; 2022 Sep; 215():109169. PubMed ID: 35753430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kynurenine pathway in depression: A systematic review and meta-analysis.
    Ogyu K; Kubo K; Noda Y; Iwata Y; Tsugawa S; Omura Y; Wada M; Tarumi R; Plitman E; Moriguchi S; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S
    Neurosci Biobehav Rev; 2018 Jul; 90():16-25. PubMed ID: 29608993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the kynurenine pathway as a potential strategy to prevent and treat Alzheimer's disease.
    Gong CY; Li Z; Wang HM; Liu J; Chen L; Zhang HW; Wang X; Yang J
    Med Hypotheses; 2011 Sep; 77(3):383-5. PubMed ID: 21683531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality.
    Bay-Richter C; Linderholm KR; Lim CK; Samuelsson M; Träskman-Bendz L; Guillemin GJ; Erhardt S; Brundin L
    Brain Behav Immun; 2015 Jan; 43():110-7. PubMed ID: 25124710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid.
    Savitz J; Ford BN; Yeh HW; Akeman E; Cosgrove K; Clausen AN; Martell C; Kirlic N; Santiago J; Teague TK; Irwin MR; Paulus MP; Aupperle RL
    Psychol Med; 2022 Oct; 52(13):2500-2509. PubMed ID: 33234171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
    Fukushima T; Umino M; Sakamoto T; Onozato M
    Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder.
    van den Ameele S; van Nuijs AL; Lai FY; Schuermans J; Verkerk R; van Diermen L; Coppens V; Fransen E; de Boer P; Timmers M; Sabbe B; Morrens M
    Bipolar Disord; 2020 Feb; 22(1):59-69. PubMed ID: 31398273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
    Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches.
    Dantzer R
    Curr Top Behav Neurosci; 2017; 31():117-138. PubMed ID: 27225497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.